Cargando…
Estimating the global burden of Epstein–Barr virus-related cancers
BACKGROUND: More than 90% of the adult population globally is chronically infected by the Epstein–Barr virus (EBV). It is well established that EBV is associated with a number of malignancies, and advances in knowledge of EBV-related malignancies are being made every year. Several studies have analy...
Autores principales: | Wong, Yide, Meehan, Michael T., Burrows, Scott R., Doolan, Denise L., Miles, John J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8752571/ https://www.ncbi.nlm.nih.gov/pubmed/34705104 http://dx.doi.org/10.1007/s00432-021-03824-y |
Ejemplares similares
-
Evaluation of plasma Epstein–Barr virus DNA as a biomarker for Epstein–Barr virus–associated Hodgkin lymphoma
por: Usha, Masuma Khatun, et al.
Publicado: (2021) -
Epstein–Barr virus infection is associated with clinical characteristics and poor prognosis of multiple myeloma
por: Xia, Bing, et al.
Publicado: (2019) -
Epstein–Barr virus and multiple sclerosis: potential opportunities for immunotherapy
por: Pender, Michael P, et al.
Publicado: (2014) -
Antitumor effects of duvelisib on Epstein–Barr virus‐associated lymphoma cells
por: Kawada, Jun‐ichi, et al.
Publicado: (2018) -
Defective T-cell control of Epstein–Barr virus infection in multiple
sclerosis
por: Pender, Michael P, et al.
Publicado: (2017)